Visuoperceptual impairment in dementia with Lewy bodies

Archives of Neurology

Volumn 57, Issue 4, 2000, Pages 489-493

  Mori, Etsuro ^a,b   Shimomura, Tatsuo ^a   Fujimori, Misato ^a   Hirono, Nobutsugu ^a   Imamura, Toru ^a   Hashimoto, Mamoru ^a   Tanimukai, Satoshi ^a   Kazui, Hiroaki ^a   Hanihara, Tokiji ^a  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

^b Hyogo Inst Aging Brain Cogn D   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGNOSIA; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELUSION; DEMENTIA; FEMALE; HUMAN; LEWY BODY; MALE; PRIORITY JOURNAL; VISUAL ACUITY; VISUAL DISCRIMINATION; VISUAL HALLUCINATION;

EID: 0034045084     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.4.489     Document Type: Article

References (38)

1. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology. 1996;47:1113-1124.
2. Ballard C, Harrison RWS, Lowery K, McKeith IG. Noncognitive symptoms in Lewy body dementia. In: Perry RH, McKeith IG, Perry EK, eds. Dementia With Lewy Bodies. New York, NY: Cambridge University Press; 1996:67-84.
3. Hirono N, Mori E, Tanimukai S, et al. Distinctive neurobehavioral features among degenerative dementias. J Neuropsychiatry Clin Neurosci. 1999;11:498-503.
4. Gnanalingham KK, Byrne EJ, Thornton A. Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndrome. Lancet. 1996;347:696-697.
5. Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's disease and Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;62:243-252.
6. Walker Z, Allen RL, Shergill S, Katona CL. Neuropsychological performance in Lewy body dementia and Alzheimer's disease. Br J Psychiatry. 1997;170:156-158.
7. Shimomura T, Mori E, Yamashita H, et al. Cognitive loss in dementia with Lewy bodies and Alzheimer disease. Arch Neurol. 1998;55:1547-1552.
8. Albin RL, Minoshima S, D'Amato CJ, Frey KA, Kuhl DA, Sima AAF. Fluorodeoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 1996;47:462-466.
9. Imamura T, Ishii K, Sasaki M, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurosci Lett. 1997;235:49-52.
10. Ishii K, Imamura T, Sasaki M, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology. 1998;51:125-130.
11. Ishii K, Yamaji S, Kitagaki H, Imamura T, Hirono N, Mori E. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology. 1999;53:413-416.
12. McShane R, Gedling K, Reading M, McDonald B, Esiri MM, Hope T. Prospective study of relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1995;59:185-188.
13. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
14. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Standlan EM. Clinical diagnosis of Alzheimer's disease. Neurology. 1984;34;939-944.
16. Mega MS, Masterman DL, Benson DF, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology. 1996;47:1403-1409.
17. Mohs RC, Rosen WG, Davis KL. The Alzheimer's Disease Assessment Scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull. 1983;19:448-450.
18. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychol. 1982;140:566-572.
19. Fujimori M, Imamura T, Yamashita H, Hirono N, Mori E. The disturbances of object vision and spatial vision in Alzheimer's disease. Dement Geriatr Cogn Disord. 1997;8:232-239.
20. Wechsler DA. Manual for the Wechsler Adult Intelligence Scale-Revised. New York, NY: Psychological Corp; 1981.
21. Adams RD, Victor M, Ropper AH. Principles of Neurology. 6th ed. New York, NY: McGraw-HillBook Co; 1997.
22. Manford M, Andermann F. Complex visual hallucinations: clinical and neurobiological insights. Brain. 1998;121:1819-1840.
23. Imamura T, Ishii K, Hirono N, et al. Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport. 1999;10:1903-1907.
24. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology. 1990;40:1-8.
25. Galasko D, Katzman R, Salmon DP, Hansen L. Clinical and neuropathological findings in Lewy body dementias. Brain Cogn. 1996;31:166-175.
26. Salmon DP, Galasko D, Hansen L, et al. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn. 1996;31:148-165.
27. Bashir K, Elble RJ, Ghobrial M, Struble RG. Hemianopsia in dementia with Lewy bodies. Arch Neurol. 1998;55:1132-1135.
28. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. J Neurol Sci. 1990;95:119-139.
29. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol. 1990;237:197-204.
30. Turjanski N, Brooks DJ. Positron emission tomography findings in Parkinson's disease and Lewy body disease. In: Perry RH, McKeith IG, Perry EK, eds. Dementia With Lewy Bodies. New York, NY: Cambridge University Press; 1996;145-152.
31. Vander Borght T, Minoshima S, Giordani B, et al. Cerebral metabolic differences in Parkinson's and Alzheimer's disease matched for dementia severity. J Nucl Med. 1997;38:797-802.
32. Bohnen NI, Minoshima S, Giordani B, Frey KA, Kuhl DE. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology. 1999;52:541-546.
33. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci. 1990;13:296-302.
34. Bulens C, Meerwaldt JD, Van der Wildt GJ, Van Deursen JBP. Effect of levodopa treatment on contrast sensitivity in Parkinson's disease. Ann Neurol. 1987;22:365-369.
35. Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci. 1990;31:2473-2475.
36. Langlaris PJ, Thai L, Hansen L, Galasko D, Alford M, Masliah E. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with or without Lewy bodies. Neurology. 1993;43:1927-1934.
37. Perry EK, Haroutunian V, Davis KL, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport. 1997;8:228-231.
38. Kuhl DE, Minoshima S, Fessler JA, et al. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol. 1996;40:399-410.